{
    "Trade/Device Name(s)": [
        "Alere i Influenza A & B",
        "Alere i Strep A",
        "Alere i RSV",
        "Alere i Influenza A & B 2"
    ],
    "Submitter Information": "Alere Scarborough, Inc.",
    "510(k) Number": "K173932",
    "Predicate Device Reference 510(k) Number(s)": [
        "K163266",
        "K151690",
        "K161375",
        "K171792"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "OCC",
        "OZE",
        "OOI",
        "PGX"
    ],
    "Summary Letter Date": "December 21, 2017",
    "Summary Letter Received Date": "December 26, 2017",
    "Submission Date": "December 21, 2017",
    "Regulation Number(s)": [
        "21 CFR 866.3980",
        "21 CFR 866.2680",
        "21 CFR 862.2570"
    ],
    "Regulation Name(s)": [
        "Respiratory viral panel multiplex nucleic acid assay",
        "Streptococcus spp Nucleic Acid-Based Assay",
        "Instrumentation for Clinical Multiplex Test Systems"
    ],
    "Analyte Class(es)": [
        "microbiology",
        "virology"
    ],
    "Analyte(s)": [
        "Influenza A viral RNA",
        "Influenza B viral RNA",
        "Streptococcus pyogenes (Group A Strep) DNA",
        "Respiratory syncytial virus (RSV) viral RNA"
    ],
    "Specimen Type(s)": [
        "Nasal swab",
        "Nasopharyngeal swab",
        "Throat swab",
        "Nasopharyngeal swab eluted in viral transport media",
        "Nasal swab eluted in viral transport media"
    ],
    "Specimen Container(s)": [
        "Viral transport media"
    ],
    "Instrument(s)/Platform(s)": [
        "Alere i Instrument"
    ],
    "Method(s)/Technology(ies)": [
        "Isothermal nucleic acid amplification"
    ],
    "Methodologies": [
        "Qualitative molecular detection",
        "Isothermal amplification"
    ],
    "Submission Type(s)": [
        "Assay",
        "Analyzer",
        "Reagent",
        "Software"
    ],
    "Document Summary": "FDA 510(k) summary for Alere i Influenza A & B, Strep A, RSV, and Influenza A & B 2 rapid, instrument-based, isothermal molecular assays with updated software algorithm.",
    "Indications for Use Summary": "Qualitative, rapid, in vitro molecular detection of influenza A and B viral RNA (nasal/nasopharyngeal swabs), Group A Streptococcus DNA (throat swabs), and RSV viral RNA (nasopharyngeal swabs) to aid in differential diagnosis of respiratory infections, in conjunction with clinical and epidemiological factors.",
    "fda_folder": "Microbiology"
}